Researchers are trying to control senile dementia

The Dementia Research Center in the United Kingdom is trying to make dementia as controllable as HIV, and if the results are significant, we can see results in the next few years. This research using recombinant mouse proteins can help a lot of people tide over, solving the problems that have plagued the medical profession for decades.

"Alzheimer's disease is expected to be under control in 2025," the team leader said, "And this study can also help the brain reconnect and reorganize the memory system eroded by the disease."

Famous Belgium psychiatric experts expressed the hope in an interview with the Associated Press that the treatment of this disease can be treated as the same as HIV treatment. He said, "The brain is the most flexible tissue of our body. If we can control the disease early in the disease, the brain can slowly restore the lost function." The team consists of multidisciplinary teams of doctors, biologists, engineers, and data specialists.

Scientists also said that in addition to "amyloid hypothesis", the scope of the study can be further expanded. Amyloid hypothesis is a long-standing focus of research in this field. According to the Post, the brain aggregate agglomerate abnormal protein called amyloid beta plaques, causing the disease.

These plaques are hallmarks of Alzheimer's disease, but the purpose of their existence is not known. In addition to the "amyloid hypothesis", there must be other signs. Alzheimer's disease is not just the case. It is certainly like cancer which is caused by the accumulation of complex factors.

"The team hopes to change the way people know about the disease through a multidisciplinary approach in the first year," the Financial Times reported. Flarebio offers high-quality recombinant proteins like recombinant CDH15 at competitive prices.